Secret, Dry Spray, (Aluminum chlorohydrate 23.5%), Antiperspirant, Waterlily, Topical Spray Can, ...

FDA Drug Recall #D-0243-2024 — Class I — November 23, 2021

Recall Summary

Recall Number D-0243-2024
Classification Class I — Serious risk
Date Initiated November 23, 2021
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm The Procter & Gamble Company
Location Cincinnati, OH
Product Type Drugs
Quantity unknown

Product Description

Secret, Dry Spray, (Aluminum chlorohydrate 23.5%), Antiperspirant, Waterlily, Topical Spray Can, Net Wt 3.8 oz (107 g), Dist. by: Procter & Gamble, Cincinnati, OH 45202. NDC: 69423-381-10; UPC 0 37000 72372 1; 12/pack UPC 0 37000 72991 4

Reason for Recall

Chemical contamination: presence of benzene

Distribution Pattern

Nationwide USA and Puerto Rico, Canada, Guam, Northern Mariana Islands, American Samoa, Bhutan, Timor-Leste, Maldives, Fiji, US Virgin Islands, Trinidad, Peru, Saint Marteen, Bahamas, Costa Rica, Guatemala, Honduras, Panama, Belize, Santa Lucia, Aruba, Dominican Republic, Guyana

Lot / Code Information

Lot #: 92191458FB, Exp 7/31/2021; 00091458SA, Exp 12/31/2021; 00091458SA, 11821458SB, Exp 6/30/2023.

Other Recalls from The Procter & Gamble Company

Recall # Classification Product Date
D-1290-2022 Class III Crest 3D White Fluoride Anticavity Toothpaste, ... Jul 8, 2022
D-0248-2024 Class II Secret OUTLAST Dry Spray, (Aluminum chlorohydra... Nov 23, 2021
D-0249-2024 Class II Old Spice Pure Sport 2021 Gift Set, Contains: O... Nov 23, 2021
D-0242-2024 Class I Secret, powder fresh, Aluminum chlorohydrate 24... Nov 23, 2021
D-0245-2024 Class II Secret, Dry Spray, (Aluminum chlorohydrate 23.5... Nov 23, 2021

Frequently Asked Questions

Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.